Clinical Study
Effects of Traumeel (Tr14) on Exercise-Induced Muscle Damage Response in Healthy Subjects: A Double-Blind RCT
Table 2
median values from all outcome parameters and the
value of median test.
| | median values | value | Placebo | Tr14 |
| Muscle damage and recovery | | | | CK | 1.7 × 106 | 1.1 × 106 | 0.05 | LDH | 1.0 × 105 | 6.1 × 104 | 0.06 | Strength (extension) | −2.7 × 105 | −2.2 × 105 | 0.87 | Strength (flexion) | −1.2 × 105 | −8.7 × 104 | 0.30 | Pain score, total | 1.2 × 105 | 1.4 × 105 | 0.36 | Pain score, VAS | 9.3 × 104 | 1.1 × 105 | 0.36 | White blood cell count | | | | Basophils | 0 | 0 | 0.85 | Basophils absolute | −5.4 | −6.9 | 0.41 | Eosinophils | −1.2 × 103 | −2.2 × 103 | 0.41 | Eosinophils absolute | −58.3 | −66.0 | 0.41 | Leukocytes | 2.2 × 103 | 3.4 × 103 | 0.92 | Lymphocytes | −1.7 × 104 | −7.9 × 103 | 0.02 | Lymphocytes absolute | −3.9 × 102 | −1.2 × 102 | 0.21 | Monocytes | −4.1 × 102 | −4.0 × 103 | 0.21 | Monocytes absolute | 1.4 × 102 | 63.2 | 0.41 | Neutrophils | 2.0 × 104 | 1.4 × 104 | 0.21 | Neutrophils absolute | 3.4 × 103 | 2.3 × 103 | 0.10 | Lymphocyte activation and apoptosis | | | | Annexin V | −1.9 × 103 | −3.7 × 103 | 0.67 | Annexin V absolute | −44.5 | −66.2 | 0.92 | CD62 | 4.1 × 103 | −4.7 × 103 | 0.21 | CD62L absolute | −2.9 × 102 | −1.6 × 102 | 0.60 | CD69 | 1.1 × 102 | 2.8 × 102 | 0.41 | CD69 absolute | −0.4 | 5.4 | 0.07 | CD95R | 3.1 × 103 | 5.9 × 103 | 0.18 | CD95R absolute | −0.8 | 36.2 | 0.20 | CD95L | −5.5 × 102 | 5.1 × 103 | 0.47 | CD95L absolute | −7.0 | 40.5 | 0.34 | Soluble inflammatory mediators | | | | CXCL8 | 4.9 × 107 | 3.0 × 107 | 0.40 | CXCL8 serum | 1.2 × 103 | 1.9 × 103 | 0.60 | CCL2 | 8.6 × 106 | 4.0 × 107 | 0.40 | CCL2 serum | 1.4 × 105 | 1.3 × 105 | 0.61 | CCL3 | 5.0 × 107 | 3.8 × 107 | 0.40 | CCL4 | 2.7 × 108 | 3.4 × 108 | 0.67 | CCL11 | −1.3 × 104 | −6.3 × 104 | 0.20 | Factor VII | 2.5 × 104 | −3.8 × 104 | 0.40 | ICAM-1 | 1.3 × 104 | −2.9 × 103 | 0.01 | IFN-γ | 2.6 × 106 | 2.3 × 106 | 0.67 | IL-1α | 2.3 × 102 | 2.6 × 102 | 0.67 | IL-1β | 1.4 × 107 | 9.0 × 106 | 0.40 | IL-1β serum | 3.8 × 102 | 3.2 × 10−7 | 0.46 | IL-1ra | 4.5 × 106 | 4.5 × 106 | 1.00 | IL-1ra serum | −4.8 × 104 | 1.8 × 104 | 0.34 | IL-2 | −2.4 × 105 | −4.0 × 104 | 0.40 | IL-4 | −3.0 × 104 | 3.8 × 104 | 0.67 | IL-5 | 1.0 × 103 | 4.6 × 103 | 0.20 | IL-6 | 3.8 × 107 | 2.9 × 107 | 0.67 | IL-6 serum | 0 | 0 | 0.50 | IL-7 | 4.0 × 104 | 3.5 × 103 | 0.67 | IL-10 | 1.9 × 105 | 2.1 × 104 | 0.40 | IL-12p40 | 2.3 × 103 | 5.0 × 103 | 0.67 | IL-12p70 | −8.6 × 104 | 1.7 × 104 | 0.03 | IL-15 | 6.1 × 102 | 5.0 × 102 | 0.40 | IL-17 | −5.4 × 103 | −3.9 × 103 | 1.00 | IL-18 | 2.0 × 105 | 1.0 × 105 | 0.09 | IL-23 | 2.8 × 103 | 5.9 × 103 | 0.67 | TNF-α | 1.2 × 107 | 1.1 × 107 | 1.00 | TNF-α serum | 0 | 0 | 0.58 | TNF-β | 5.9 × 103 | 6.0 × 103 | 1.00 | Growth factors | | | | BDNF | 4.5 × 103 | −1.9 × 102 | 0.03 | GM-CSF | 2.0 × 104 | 7.5 × 104 | 0.09 | IL-3 | 9.4 | 0.8 | 0.40 | SCF | 5.7 × 105 | 2.4 × 105 | 0.09 | VEGF | 1.2 × 105 | 8.1 × 104 | 0.40 | Matrix metalloproteinases | | | | MMP-3 | 5.3 × 103 | 3.9 × 103 | 0.20 | MMP-9 | 6.3 × 104 | 5.0 × 104 | 0.40 | Acute phase protein | | | | CRP | 2.4 × 103 | 2.3 × 103 | 0.76 |
|
|
BDNF: brain-derived neurotrophic factor; CK: creatine kinase; CRP: C-reactive protein; GM-CSF: granulocyte macrophage colony-stimulating factor; ICAM-1: intercellular adhesion molecule 1; IFN-γ: interferon-gamma; LDH: lactate dehydrogenase; MMP: matrix metalloproteinase; SCF: stem cell factor; TNF: tumor necrosis factor; VEGF: vascular endothelial growth factor.
|